B · Normal
[Sunflower: Subsidiary obtains Drug Registration Certificate for Glucosamine Sulfate Capsules] On September 4th, Sunflower (300111.SZ) announced that the company’s subsidiary Zhejiang Beide Pharmaceutical recently received the Drug Registration Certificate for Glucosamine Sulfate Capsules issued by the Food and Drug Administration. This drug is suitable for primary and secondary osteoarthritis. The registration classification is Category 4 chemical drugs. It is deemed to have passed the consistency evaluation and has been included in Category B of the National Medical Insurance Catalog. Obtaining this certificate will improve the company's product structure and help enhance market competitiveness.
Comments